免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

NCT:NCT07271238 · RECRUITING

NCT编号NCT07271238
状态RECRUITING
开始日期2026-03-03
完成时间2026-10-15
SponsorLUMA Vision Ltd. (INDUSTRY)
First posted
Last updated

简要摘要

The objective of the study is to collect data on the usability and integration of the VERAFEYE Imaging and Guidance System in adult patients indicated to undergo a standard of care catheter-based ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or persistent AF (perAF). Results from this study may be used to guide development and refinement the VERAFEYE Imaging and Guidance System capabilities.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑